Erratum in: Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib
Takuya Araki, Hideaki Yashima, Kimihiro Shimizu and 5 more
Clinical Medicine Insights: Oncology · 2013
doi:10.4137/cmo.s11910 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
This article (Clinical Medicine Insights: Oncology. 2012;6:407–21. doi: 10.4137/CMO.S7340) is corrected at the request of the original authors. Table 2 contains an error. The table compares gefitinib to placebo in the INTEREST trial. In this trial, gefitinib was compared to Docetaxel and not placebo.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.